腹腔镜与机器人辅助直肠癌手术对比:COLRAR随机对照试验
该随机对照试验纳入295例距肛缘<10 cm、临床分期T1-4aNxM0的直肠腺癌患者,比较机器人辅助TME与腹腔镜辅助TME。因入组缓慢提前终止。两组完整TME率无差异,R-TME组环周切缘阳性率在亚组分析中更低,阿片类药物使用时间更短。
要点
- 机器人辅助TME在完整TME率上未显著优于腹腔镜TME。
- 亚组分析中R-TME环周切缘阳性率低于L-TME(0% vs 6.1%)。
- R-TME组阿片类药物使用时间更短,术后并发症率两组无差异。
核心结论
- 在中低位直肠癌患者中,机器人辅助手术相比传统腹腔镜手术未显著改善TME质量。
研究设计与样本
- 多中心随机对照试验,2011年7月至2016年2月入组,因入组缓慢提前终止;共295例患者随机分为R-TME组151例和L-TME组144例。
主要发现
- 完整TME率R-TME组80.7%、L-TME组77.1%,两组无差异。
- 环周切缘及检出淋巴结数量等病理结局两组无差异。
- 亚组分析中R-TME组环周切缘阳性率0%,L-TME组6.1%(P=0.031)。
- R-TME组阿片类药物使用时间更短(P=0.028)。
- 术后并发症率R-TME组12.0%、L-TME组8.3%,两组无差异。
关键数值与推荐
- 纳入标准:距肛缘<10 cm的腺癌,临床评分为T1-4aNxM0。
- 主要结局:由外科医生和病理学家评估的TME完整性。
临床怎么用
- 对于中低位直肠癌,机器人辅助TME可作为腹腔镜TME的替代选择,但需结合亚组分析中环周切缘阳性率降低及阿片类药物使用减少的潜在优势综合考量。
局限性
- 试验因入组缓慢提前终止,可能影响统计效能。
- 环周切缘阳性率差异来自亚组分析,需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate whether robotic for middle or low rectal cancer produces an improvement in surgical outcomes compared with laparoscopic surgery in a randomized controlled trial (RCT). BACKGROUND: There is a lack of proven clinical benefit of robotic total mesorectal excision (TME) compared with a laparoscopic approach in the setting of multicenter RCTs. METHODS: Between July 2011 and February 2016, patients diagnosed with an adenocarcinoma located <10 cm from the anal verge and clinically rated T1-4aNxM0 were enrolled. The primary outcome was the completeness of TME assessed by a surgeon and a pathologist. RESULTS: The RCT was terminated prematurely because of poor accrual of data. In all, 295 patients were assigned randomly to a robot-assisted TME group (151 in R-TME) or a laparoscopy-assisted TME group (144 in L-TME). The rates of complete TME were not different between groups (80.7% in R-TME, 77.1% in L-TME). Pathologic outcomes including the circumferential resection margin and the numbers of retrieved lymph nodes were not different between groups. In a subanalysis, the positive circumferential resection margin rate was lower in the R-TME group (0% vs 6.1% for L-TME; P =0.031). Among the recovery parameters, the length of opioid use was shorter in the R-TME group ( P =0.028). There was no difference in the postoperative complication rate between the groups (12.0% for R-TME vs 8.3% for L-TME). CONCLUSIONS: In patients with middle or low rectal cancer, robotic-assisted surgery did not significantly improve the TME quality compared with conventional laparoscopic surgery (ClinicalTrial.gov ID: NCT01042743).
引用
- Park JS, Lee SM, Choi GS, et al. Comparison of Laparoscopic Versus Robot-Assisted Surgery for Rectal Cancers: The COLRAR Randomized Controlled Trial. Ann Surg. 2023. PMID: 36594748. doi:10.1097/SLA.0000000000005788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。